Celea Therapeutics Announces $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF) Celea Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing transformative treatments for people with serious respiratory diseases, today…
PureTech Founded Entity Celea Therapeutics Completes $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF) PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation…
AGC Pharma Chemicals Validates Facilities for CDMO Services via Scientist.com’s VERIF.i® Program Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) for small molecule…
Bayer Group to Consolidate U.S. Glyphosate Business Into a Distinct Entity Operating as Ruveon Bayer Group announced the consolidation of the U.S. glyphosate business into Ruveon LLC to optimize and align the business with the specific needs of the U.S.…
In Line With the LEAP | 28 Portfolio Rotation Strategy, Bureau Veritas Signs an Agreement to Sell Its Oil & Petrochemicals and Coal Testing and Inspection Business Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces…
BASF and Pune Knowledge Cluster (PKC) of The Principal Scientific Advisor’s Office celebrate four years of WEnyan BASF Chemicals India Private Limited (BCIPL), in collaboration with the Pune Knowledge Cluster (PKC) of PSA’s office, successfully celebrated the completion of four…
Merck Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets Merck, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive…
Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test Verici Dx plc a developer of advanced clinical diagnostics for organ transplant, announced it has received clinical laboratory accreditation from the New York State…
ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development ICON plc announced that it has selected Microsoft as a preferred technology partner – further advancing ICON’s previously announced plan to invest in digital innovation and AI…
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer Pfizer Inc. announced topline results from the Phase 3 SigVie-002 study (previously known as Be6A Lung-01) evaluating sigvotatug vedotin, an investigational, potential…
BIOTECanada Opens Canada Pavilion at BIO 2026 Amid Major Policy Momentum for Canadian Biotech BIOTECanada officially opened the Canada Pavilion today at the BIO International Convention in San Diego, serving as the central hub for Canadian biotechnology companies to showcase…
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases Bionyra Pharma, a clinical-stage biopharmaceutical company developing next-generation biologics for immune-mediated inflammatory diseases, today announced the company’s launch…